Mark S Ordan insider trades: Pediatrix Medical Group (MD) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
and 4 more companies
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | MD | ↓ Sell | 23,000 | $22.41 | $515K | Direct | Dec 17, 2025 (2d) |
| Nov 13, 2024 | MD | ↓ Sell | 27,600 | $15.35 | $424K | Direct | Nov 14, 2024 (1d) |
| May 25, 2023 | MD | ↓ Sell | 33,000 | $13.26 | $438K | Direct | May 26, 2023 (1d) |
| Nov 21, 2022 | MD | ↓ Sell | 22,166 | $15.45 | $342K | Direct | Nov 23, 2022 (2d) |
| Aug 30, 2021 | MD | ↓ Sell | 95,000 | $35.09 | $3.3M | Direct | Aug 31, 2021 (1d) |
| Jun 11, 2015 | WPG | ↑ Buy | 25,000 | $13.30 | $333K | Direct | Jun 15, 2015 (4d) |
| Nov 20, 2014 | WPG | ↑ Buy | 10,000 | $17.13 | $171K | Direct | Nov 20, 2014 (0d) |
| Nov 7, 2014 | WPG | ↑ Buy | 10,000 | $17.79 | $178K | Direct | Nov 10, 2014 (3d) |
| Nov 7, 2014 | WPG | ↑ Buy | 5,000 | $17.78 | $89K | Held by trust for the benefit of the rep | Nov 10, 2014 (3d) |
| Dec 5, 2012 | SRZ | ↓ Sell | 333,333 | $14.38 | $4.8M | Direct | Dec 5, 2012 (0d) |
| Nov 23, 2012 | SRZ | ↓ Sell | 642,958 | $14.30 | $9.2M | Direct | Nov 26, 2012 (3d) |
| Nov 20, 2012 | SRZ | ↓ Sell | 881,214 | $14.31 | $12.6M | Direct | Nov 20, 2012 (0d) |
| Nov 15, 2012 | SRZ | ↓ Sell | 84,161 | $14.30 | $1.2M | Direct | Nov 16, 2012 (1d) |
| Mar 27, 2012 | SRZ | ↓ Sell | 225,000 | $7.36 | $1.7M | Direct | Mar 27, 2012 (0d) |
| Sep 29, 2006 | FRT | ↓ Sell | 2,400 | $74.23 | $178K | Direct | Oct 2, 2006 (3d) |
| Jun 20, 2006 | FRT | ↓ Sell | 1,000 | $67.81 | $68K | Direct | Jun 21, 2006 (1d) |
| Dec 8, 2005 | FRT | ↓ Sell | 750 | $62.50 | $47K | Direct | Dec 9, 2005 (1d) |
| Jun 7, 2005 | FRT | ↓ Sell | 1,800 | $57.31 | $103K | Direct | Jun 8, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MD insiders
Open-market trades in the last 12 months
About Mark S Ordan's insider trades
Mark S Ordan is Chief Executive Officer at Pediatrix Medical Group (MD). Since Jun 7, 2005, Mark has reported 4 open-market purchases worth $771K and 14 sales worth $34.9M on SEC Form 4. In the last 12 months: 1 sale ($515K).
Their filings also include grants and awards (50 filings), shares withheld for taxes (11 filings), option exercises (9 filings), shares returned to the company (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.